Artículos del autor

solaci

Discover the Scientific Preliminary Program and Register to the Congress

READ THE PRELIMINARY SCENTIFIC PROGRAM At SOLACI-SOCIME 2022 you will be able to enjoy -throughout 3 days -...

Tricuspid Regurgitation: Edge-to-Edge Treatment with PASCAL

About 4% of the population suffers from tricuspid regurgitation (TR). This disease is associated with hard-to-manage heart...

Changes in Coronary Collateral Function Post CTO Intervention

In the last few years, we have seen significant growth of chronic total occlusion (CTO) percutaneous intervention,...

Thin vs. Ultrathin Stents: 1-Year Clinical Results After IVUS/OCT-Guided Implantation

Second generation drug-eluting stents have lower frequency of thrombotic complications and in-stent restenosis. While clinical results have...

Angioplasty in Nonagenarians Is Increasingly Frequent: How Does It Evolve?

Currently, the number of nonagenarian patients undergoing angioplasty (whether elective, urgent or emergency) has increased.  This population is...

‘+25 International Guests Will Be Sharing their Knowledge at SOLACI-SOCIME 2022

+25 INTERNATIONAL GUESTS WILL BE SHARING THEIR KNOWLEDGE AT SOLACI-SOCIME 2022 Why is SOLACI-SOCIME 2022 an unmissable event...

Register to the SOLACI-SOCIME 2022 Virtual Sessions

REGISTER TO THE CONGRESS VIRTUAL SESSIONS This year, SOLACI-SOCIME 2022 will stream live all scientific sessions at the Main Arena from...

TRICVALVE in Patients with Severe Tricuspid Regurgitation: Promising Results at 6 months

Severe tricuspid regurgitation (TR) is associated with high mortality and morbidity. For patients with high surgical risk...